Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Geron Corp (NASDAQ:GERN)

2.84
Delayed Data
As of Jul 27
 -0.09 / -3.07%
Today’s Change
1.81
Today|||52-Week Range
3.15
+37.20%
Year-to-Date

Today’s Trading

Previous close2.93
Today’s open2.95
Day’s range2.81 - 2.96
Volume1,151,506
Average volume (3 months)1,603,785
Market cap$466.4M
Dividend yield--
Data as of 3:59pm ET, 07/27/2017

Growth & Valuation

Earnings growth (last year)-63,433.33%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)-83.06%
P/E ratioNM
Price/Sales53.43
Price/Book3.81

Competitors

 Today’s
change
Today’s
% change
AGENAgenus Inc-0.78-14.83%
ATRAAtara Biotherapeutic...-0.25-1.62%
RXDXIgnyta Inc+0.05+0.54%
ADAPAdaptimmune Therapeu...-0.10-1.83%
Data as of 4:14pm ET, 07/27/2017

Financials

Next reporting dateAugust 2, 2017
EPS forecast (this quarter)-$0.05
Annual revenue (last year)$6.2M
Annual profit (last year)-$29.5M
Net profit margin-479.34%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
John A. Scarlett
Chief Financial Officer, Treasurer &
Executive VP
Olivia K. Bloom
Corporate headquarters
Menlo Park, California

Forecasts